The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation (...
read more
Ractigen Therapeutics, announced that the FDA approved the company's Investigational New Drug (IND) application for RAG-01, a groundbreaking saRNA ...
read more
Increasing incidence of cancer followed by awareness for early diagnosis, growing investments in research and development of cancer biomarkers, ...
read more
TriLink BioTechnologies has signed a non-exclusive License and Supply Agreement with Lonza. This agreement with Lonza strengthens TriLink’s objective ...
read more
Editas Medicine, Inc. announced a two-year extension to the collaboration with Bristol Myers Squibb under which the parties may research, develop, and...
read more
Astellas Pharma Inc. and Poseida Therapeutics, Inc. announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and ...
read more
Wacker Biotech US, a subsidiary of WACKER, specializing in the fermentative production of plasmid DNA (pDNA), is expanding its mRNA and protein ...
read more
KromaTiD, a company focused on the research, development, and commercialization of single-cell genomics tools and services for the Cell and Gene ...
read more
MetP Pharma AG, leveraging the proprietary nose-to-brain drug delivery technology BrainDos™ in internal and external product development and ...
read more
Minaris Regenerative Medicine, a global manufacturing partner to the cell and gene therapy industry, today announced that the first commercial ...
read more
ProQR Therapeutics, a company dedicated to changing lives through transformative RNA therapies, announced new preclinical data for its proprietary ...
read more
In response to President Biden's Executive Order 14081, "Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure ...
read more
evitria AG, a global antibody expression service provider located in Zurich, Switzerland, has entered into a non-exclusive bYlok® bispecific pairing ...
read more
Takeda and AC Immune SA announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of...
read more
Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs, and Retro Biosciences (Retro), a ...
read more